We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWS icon
526
iShares MSCI Singapore ETF
EWS
$1.01B
$210K ﹤0.01%
7,870
FUN icon
527
Cedar Fair
FUN
$1.78B
$209K ﹤0.01%
4,431
LEG icon
528
Leggett & Platt
LEG
$1.52B
$209K ﹤0.01%
5,972
-100
-2% -$3.43K
AWK icon
529
American Water Works
AWK
$26.3B
$208K ﹤0.01%
4,315
+59
+1% +$2.88K
VOE icon
530
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$208K ﹤0.01%
2,447
CBI
531
DELISTED
Chicago Bridge & Iron Nv
CBI
$208K ﹤0.01%
3,595
-52,304
-94% -$3.3M
ACTG icon
532
Acacia Research
ACTG
$450M
$194K ﹤0.01%
12,509
-931
-7% -$15.7K
CSV icon
533
Carriage Services
CSV
$618M
$185K ﹤0.01%
+10,696
New +$188K
AA icon
534
Alcoa
AA
$11.7B
$177K ﹤0.01%
4,578
-416
-8% -$16.3K
NLY icon
535
Annaly Capital Management
NLY
$16.9B
$168K ﹤0.01%
3,925
HZNP
536
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$137K ﹤0.01%
11,150
MNKD icon
537
MannKind Corp
MNKD
$1.28B
$136K ﹤0.01%
+4,604
New +$182K
SVLC
538
DELISTED
SILVERCREST MINES INC ORD SHS (CDA)
SVLC
$134K ﹤0.01%
90,000
-20,000
-18% -$38.6K
EWJ icon
539
iShares MSCI Japan ETF
EWJ
$21.7B
$130K ﹤0.01%
2,760
+166
+6% +$7.93K
DNDN
540
DELISTED
DENDREON CORPORATION
DNDN
$115K ﹤0.01%
79,800
+13,000
+19% +$22.8K
FTR
541
DELISTED
Frontier Communications Corp.
FTR
$107K ﹤0.01%
1,091
AMZG
542
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
$102K ﹤0.01%
25,150
ARNA
543
DELISTED
Arena Pharmaceuticals Inc
ARNA
$101K ﹤0.01%
+2,420
New +$108K
ELI
544
DELISTED
ELITE PHARMACEUTICAL
ELI
$93K ﹤0.01%
290,880
+10,450
+4% +$3.34K
BDJ icon
545
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
$92K ﹤0.01%
11,216
MDW
546
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$87K ﹤0.01%
84,100
WEN icon
547
Wendy's
WEN
$1.33B
$84K ﹤0.01%
+10,165
New +$83.3K
SIRI icon
548
SiriusXM
SIRI
$10B
$79K ﹤0.01%
2,273
+980
+76% +$34.3K
PLM
549
DELISTED
PolyMet Mining Corp.
PLM
$75K ﹤0.01%
6,980
-500
-7% -$5.77K
ECT
550
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$67K ﹤0.01%
+12,200
New +$81.8K

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.